Randomised Controlled Trials
|
|
- Heather Johnson
- 6 years ago
- Views:
Transcription
1 Randomised Controlled Trials Dr John Stephenson Senior Lecturer in Biomedical/Health Statistics School of Human and Health Sciences University of Huddersfield Huddersfield, GB-HD1 3DH Staff profile:
2 Introduction who am I? I am a biomedical statistician I work collaboratively with colleagues from: UoH Schools of Human & Health Sciences and Applied Sciences Clinicians from various Health Service Trusts around Britain Medical companies and other commercial organisations Other universities in Britain, Australia and elsewhere On projects in fields such as: Tissue viability, spinal surgery, pharmaceutical sciences, clinical education, etc... I provide: Advice on quantitative study design, sample size calculations etc. Statistical methods and results sections of articles, reports and conference items
3 Where did you say you were from again? Huddersfield (pop. 130,000) 300 km N of London 50 km E of Manchester
4 Huddersfield
5 Summary Overview/types of RCT Sampling how, how many, who? Randomisation why, how? Variables predictors, endpoints Participant flow Data analysis Data presentation
6 What is an RCT? an overview A study in which participants are randomly allocated to 2 (or more) groups to test a specific drug, therapy or treatment ( intervention ) 1 or more groups (the experimental or intervention group(s)) receives treatment(s) being tested 1 group (the comparison or control group) receives either: alternative treatment ( positive control ), or placebo or nothing ( negative control )
7 What is an RCT? an overview Groups followed up to see how effective the experimental treatment was Outcomes measured at specific times Any difference in response between the groups assessed statistically
8 The first controlled trial? A report of a controlled study 2600 years ago in the Bible (Daniel 1:11-16) Daniel proposed a study to compare: a group who ate vegetables and water for ten days a group who ate royal food and wine from the table of Nebuchadnezzar the king of Babylon Those with the vegetarian diet were better nourished than those who ate royal food
9 RCTs in the modern era Statistical methods for RCTs formulated by Gossett in 1900s Further developed by Fisher in 1920s First RCT directed by Austin Bradford Hill in 1946 Demonstrated benefits of streptomycin in treatment of TB By 1970s, RCTs were commonplace
10 Hierarchy of Evidence Health services and other organisations consider RCTs to be near the top of hierarchy of evidence Mostly systematic reviews of RCTs! From Australian Institute of Family Studies,
11 Types of RCT Parallel Most common form of RCT (recent PubMed survey 1 found 78% of all RCTs to be parallel) Patient receives one of two or more treatments being compared Cross-over Every participant gets each treatment in random order Separated by wash-out period to avoid carry-over effects 1 Hopewell et al., BMJ 2010;340:c723
12 Types of RCT Pragmatic RCTs Test effectiveness in everyday practice Relatively unselected participants Flexible conditions Inform decisions about practice Explanatory RCTs (less common) Test efficacy in research setting Controlled conditions May use specially selected participants
13 Sampling for RCTs A sample should be representative of the population Sampling method (random / non-random) should be made clear Random sampling may be preferred on statistical grounds Simple random sampling Systematic sampling Cluster/multistage sampling etc. Non-random sampling much more widely used in health research Quota Convenience etc.
14 How many? Appropriate sample size is essential for an ethical trial Sample should be large enough to detect a meaningful difference between groups (if one exists) Sample too small trial may be unethical Potential risk to patients participating in study that cannot answer its research question Sample too large waste of time and resources No statistical disbenefits in general Patients could be harmed by unnecessary delay in treatment introduction
15 How many? Sample size depends on many factors: Required power of study (probability of detecting a real effect) Significance level (maximum probability of falsely claiming a real effect) Variability of observations Size of effect required to be detected
16 How many? Significance level should be as low as possible 5% significance level often specified Chance of type I error (falsely claiming a real effect) = 5% Lower significance levels require larger samples Power should be as high as possible 80% power most commonly specified Chance of type II error (failing to detect a real effect) = 20% Greater power requires larger samples
17 Estimates of sample size Higher variability of data requires larger samples Variability not usually known before start of study Can be estimated using pilot studies or the literature Detection of smaller effects requires larger samples Confidence that an observed difference not random noise Difficult to definitively ascribe smaller changes to treatment Previous research can provide estimates of effect size
18 Typical Huddersfield University sample size conversation (1) Clinician: How many patients do I need for a trial of my patent Yellow Swamp Fever antidote? Statistician: But I need to know the data variability, the expected effect of interest, significance level, study power, how many groups in the trial, relative group sizes Clinician: (sticking fingers in ears): No idea. You re the statistician. Just tell me how many I need. That s what we pay you for. Statistician:
19 Typical Huddersfield University sample size conversation (2) Clinician: I need a sample size calculation for a funding bid I m writing. I want to use messy and incomplete data to test lots of variables, whose effect on multiple outcomes measured at several time points is probably very small. Statistician: Goodness me! I think you ll need a very large sample. Give me the details and I ll just work it out. Clinician: Make sure the answer is 36. That s as many patients as I ve got. Statistician:
20 Inclusion/exclusion criteria Define which patients are to be recruited Numbers assessed for eligibility, and those excluded from trial should be recorded Exclusions comprise: refusals; those not meeting inclusion criteria
21 Inclusion/exclusion criteria Typical sample criteria for a RCT assessing quality of life in Type 2 diabetic patients with non-infected surgical wounds Inclusion criteria: Patients over 18 years Have type 2 diabetes Have a non-infected surgical wound Are able to speak and understand English Are mentally alert and able to give informed consent Exclusion criteria: Patients under 18 years old Diabetes type 1 or no diabetes Have an infected wound/ulcer or no wound Unable to speak or understand English Cannot give informed consent
22 Treatment allocation Patients allocated to treatment group on entering trial by process of random allocation (randomisation) Computer generated random numbers, random number tables, opaque sealed envelopes, dice, coins, balls in a bag etc. Allocation concealment: participants should have no prior knowledge about the intervention they will receive Allocation usually (but not always) in 1:1 ratio
23 Why do we randomise? Avoids systematic differences between groups Promotes - but does not guarantee - similarity in terms of baseline characteristics (both known and unknown) Statistical methods available to adjust for variations in baseline covariates between groups if necessary
24 Complete randomisation Every participant is randomly assigned to a treatment (e.g. control or intervention) Simple design: may not necessarily control for all variability
25 Restricted randomisation (a.k.a. block randomisation) Suppose you are planning to recruit 40 patients to a trial You prepare 40 sealed envelopes for allocation (20 control, 20 treatment) Patients randomised; commence treatment on recruitment Unfortunately, fewer patients are recruited than anticipated You realise that you will only get 24 patients in the available time You subsequently find that by chance 17 patients have been randomised to control and only 7 to treatment Imbalance could have been avoided using restricted randomisation
26 Restricted randomisation (a.k.a. block randomisation) Randomize participants into groups of equal sizes For 2-arm study, participants grouped into blocks of 2, 4, etc. Participants in each block distributed equally across treatments Keeps numbers of participants in each group similar at all times Matched pairs studies always use this form of randomisation
27 Stratified randomisation Suppose we have 100 patients (40 men and 60 women) available for 2-arm trial Assume gender is known to be a strong predictor of the outcome Gender is a source of unwanted variability (a blocking factor) We need to control for gender, by ensuring a gender balance at baseline
28 Stratified randomisation Complete randomisation: could give us (say): Control: 10 men, 40 women Treatment: 30 men, 20 women Possible confounding bias Conduct separate randomisation schemes for each gender stratified randomisation (by gender) This would give us: Control: 20 men, 30 women Treatment: 20 men, 30 women No confounding by gender
29 Cluster randomisation Consider a study testing effect on educational program administered to student nurses If applied, program must be applied across a whole school Schools randomised to receive or not receive program All students in each school have same program status Avoids practical difficulties of multiple treatments within same school School 1: Control Randomisation at school level School 2: Treatment Nurse 1: Control Nurse 2: Control Nurse 3: Control Nurse 1: Treatment Nurse 2: Treatment Nurse 3: Treatment
30 Blinding Assessment bias may arise if clinicians and/or patients aware of treatment allocation i.e. not blinded All participants (clinicians/assessors, patients) should be blinded where possible Not always possible e.g. assessment of surgical procedures Treatment may cause side-effects Clinicians/assessors and patients unaware of treatment allocation double blinded trial Clinicians/assessors only blinded single blinded trial
31 Pilot studies If time permits, a pilot study may be conducted before the main study Evaluate feasibility: time, cost, adverse events, etc. What is the compliance rate for my treatment? Have I allowed enough time for the treatment to take effect? Have I optimised the treatment parameters? Can also assess data variability to help predict sample size for main study
32 Variables Many possible variables may be recorded But analysis of comparability between groups normally restricted to those known to be strong predictors of primary outcome In many RCTs the treatment variable is the only predictor Categorical variable with (typically) 2 levels: control & intervention Large studies & effective randomisation well balanced groups no need to control for other factors Best to specify a single primary outcome a priori: any other outcomes defined to be secondary outcomes
33 Multiple outcome variables Multiple outcomes can lead to fishing expeditions Fishing the data for a favourable outcome; discarding less favourable ones! Rigorous treatment of multiple outcomes can be very complex which is maybe why it is not done properly in 1000 s of published trials!
34 Ethical issues All RCTs must be passed by an ethics committee Judge that trial does not contravene the Declaration of Helsinki Informed patient consent is required before patients entered into trial
35 Participant flow For each group, we need to report numbers of participants : Randomly assigned Receiving intended treatment Completing study protocol Analysed for primary outcome Summarised in CONSORT (Consolidated Standards of Reporting Trials) flowchart
36 CONSORT flow diagram
37 Example participant flowchart For RCTs, Methods section often includes flowchart summarising patient involvement at every stage of the study like this one for a diet trial From Truby et al. (2006), BMJ, doi: / bmj
38 Participant flow Substantial proportions of participants lost at any stage may reduce external validity of trial Those remaining may no longer be representative of those eligible Imbalance in losses between treatment groups may reduce internal validity of trial Could lead to non-random differences between treatment groups, which could influence outcome
39 Data analysis: descriptive As in other quantitative research designs, most RCTs include a descriptive summary of the data May include summary statistics in text, tables and/or graphs Both baseline and post-treatment results usually provided Participant characteristics usually summarised both by group and as a whole cohort
40 Data analysis: inferential Statistical processes used in the analysis of RCTs usually require to assess differences or ratios in group means or proportions Independent samples t-test, Mann-Whitney U test, analysis of variance (ANOVA), analysis of covariance (ANCOVA), chi-squared test, Kruskal-Wallis test, log-rank test, multivariate ANOVA All common tests available on standard statistical packages Tests for single sample studies, pre-post ( paired ) studies and repeated measures not suitable for the main comparative analysis of RCTs Single sample t-test, sign test, paired samples t-test, Wilcoxon signed ranks test, repeated measures ANOVA, Friedman test, McNemar s test
41 Reporting the analysis key statistics Group characteristics at baseline Magnitude of the treatment effect; e.g. Mean value of outcome in both groups, and the difference between them Incidence of condition in both groups, plus risk/odds ratio for treatment group Number needed to treat (NNT) may be reported if appropriate Number needed to receive new treatment to prevent 1 adverse occurrence Test statistics, p-values and confidence intervals from inferential tests
42 P-values Ubiquitous statistic that very few people seem to properly understand! Assesses the significance of the test Is any observed difference due to sampling error or a real effect? Firstly assume there is no difference between treatment groups Then the p-value is the probability that we would get the result we just got (or an even more extreme one) Greater than a given cut-off (usually 5%) findings could just be sampling error Don t claim anything! Less than the cut-off assume findings represent a real treatment effect Claim something!
43 Confidence intervals Assess the precision of the effect We derive an estimate from our sample The precise value in the population will never be known But we can derive an interval within which (broadly speaking) we are 95% confident that the true value lies Lower limit Best estimate of treatment effect Upper limit 95% confidence interval
44 Descriptive data analysis baseline summary Typical presentation of group characteristics at baseline Variables here are a mixture of interval/ratio and categorical Mean and SD used for summarising interval/ratio variables Frequencies and/or proportions/percentages used to summarise categorical variables From Bleakley et al., BMJ 2010;340:c1964 doi: /bmj.c1964
45 Options for graphical presentations (1) Line graph showing readings taken from control and treatment groups at different time points, with associated confidence intervals around points in each group Dot plot showing differences between control and treatment groups at different time points, also with associated confidence intervals Both taken from Bleakley et al., BMJ 2010;340:c1964 doi: /bmj.c1964
46 Options for graphical presentations (2) Comparison of numerical data Box plot showing medians, ranges and inter-quartile ranges readings from control and treatment groups on outcome measure From Azouz et al., Journal of Aerosol Medicine and Pulmonary Drug Delivery, 27 (3), pp
47 Options for graphical presentations (3) Comparison of categorical data Clustered bar chart: each pair of bars shows proportion of patients in each group giving labelled response Difficult to get picture of overall treatment performance From Cameron et al. (2005), Journal of Wound Care 14 (5) pp
48 Options for graphical presentations (4) Survival analysis curves compare survival over time of patients in control and treatment groups From Prentice, R. L. et al. JAMA 2006;295:
49 Subgroup analysis Subgroup analyses are widespread in published RCTs For example, males and females, or older and younger participants, analysed separately Why is this not always a good idea?
50 Sub-group analysis Smaller studies reduced study power Less likely to detect any treatment effect that may exist Multiple comparisons increased type I error rates Probability of falsely claiming a non-existent effect that does not exist Difficult to interpret results Significant result in one subgroup, but not another, is not evidence that treatment effect differs between subgroups
51 So when SHOULD we use subgroups, then? When there is a clear a priori reason to expect different treatment effects in the groups Example: effect of exercise programme on body fat % might be expected to be very different in men and women Statistical methods of control also available In multi-centre trials; may be useful to present results by centre as well as pooled results and means of data quality/consistency checking
52 Common errors in RCT data analysis (1) Use of statistical tests to compare patient characteristics in study groups at baseline Any differences can ONLY be due to sampling error so what s the point of the test? Non-significant imbalances of strong predictors may have more effect than a significant imbalance on a weak or unrelated one Multiple outcomes analysed independently No consideration of correlations between multiple outcome variables Inflated error rates
53 Common errors in RCT data analysis (2) Lots of variables, not enough data Rule of thumb: at least 10 cases per variable May need to control for covariates if groups unequal at baseline Disregarding data from large proportion of patients lost to follow-up in longitudinal RCT Unnecessarily classifying raw data into groups Loses information No account for clustering of data in cluster RCTs More advanced statistical treatment required
54 CONSORT checklist
55 CONSORT checklist
56 Conclusions RCTs the gold standard of experimental design Unpaired study; characterised by: Use of control group in addition to treatment group(s) to promote internal validity Randomisation of participants to groups (various methods available) Requires representative samples of adequate size Flow of participants through trial monitored Analysed with a range of descriptive and inferential statistical methods
57 Thank you for your attention!
CHL 5225 H Advanced Statistical Methods for Clinical Trials. CHL 5225 H The Language of Clinical Trials
CHL 5225 H Advanced Statistical Methods for Clinical Trials Two sources for course material 1. Electronic blackboard required readings 2. www.andywillan.com/chl5225h code of conduct course outline schedule
More informationPOST GRADUATE DIPLOMA IN BIOETHICS (PGDBE) Term-End Examination June, 2016 MHS-014 : RESEARCH METHODOLOGY
No. of Printed Pages : 12 MHS-014 POST GRADUATE DIPLOMA IN BIOETHICS (PGDBE) Term-End Examination June, 2016 MHS-014 : RESEARCH METHODOLOGY Time : 2 hours Maximum Marks : 70 PART A Attempt all questions.
More informationCritical Appraisal Series
Definition for therapeutic study Terms Definitions Study design section Observational descriptive studies Observational analytical studies Experimental studies Pragmatic trial Cluster trial Researcher
More informationIssues to Consider in the Design of Randomized Controlled Trials
Issues to Consider in the Design of Randomized Controlled Trials Jay Wilkinson, MD, MPH Professor of Pediatrics & Epidemiology Miller School of Medicine Seminar Purpose To facilitate an interactive discussion
More informationRandomized Controlled Trial
Randomized Controlled Trial Training Course in Sexual and Reproductive Health Research Geneva 2016 Dr Khalifa Elmusharaf MBBS, PgDip, FRSPH, PHD Senior Lecturer in Public Health Graduate Entry Medical
More informationCONSORT 2010 Statement Annals Internal Medicine, 24 March History of CONSORT. CONSORT-Statement. Ji-Qian Fang. Inadequate reporting damages RCT
CONSORT-Statement Guideline for Reporting Clinical Trial Ji-Qian Fang School of Public Health Sun Yat-Sen University Inadequate reporting damages RCT The whole of medicine depends on the transparent reporting
More informationCONSORT 2010 checklist of information to include when reporting a randomised trial*
CONSORT 2010 checklist of information to include when reporting a randomised trial* Section/Topic Title and abstract Introduction Background and objectives Item No Checklist item 1a Identification as a
More informationDownloaded from:
Arnup, SJ; Forbes, AB; Kahan, BC; Morgan, KE; McKenzie, JE (2016) The quality of reporting in cluster randomised crossover trials: proposal for reporting items and an assessment of reporting quality. Trials,
More informationCRITICAL EVALUATION OF BIOMEDICAL LITERATURE
Chapter 9 CRITICAL EVALUATION OF BIOMEDICAL LITERATURE M.G.Rajanandh, Department of Pharmacy Practice, SRM College of Pharmacy, SRM University. INTRODUCTION Reviewing the Biomedical Literature poses a
More informationSystematic reviews and meta-analyses of observational studies (MOOSE): Checklist.
Systematic reviews and meta-analyses of observational studies (MOOSE): Checklist. MOOSE Checklist Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease:
More informationThe comparison or control group may be allocated a placebo intervention, an alternative real intervention or no intervention at all.
1. RANDOMISED CONTROLLED TRIALS (Treatment studies) (Relevant JAMA User s Guides, Numbers IIA & B: references (3,4) Introduction: The most valid study design for assessing the effectiveness (both the benefits
More informationControlled Trials. Spyros Kitsiou, PhD
Assessing Risk of Bias in Randomized Controlled Trials Spyros Kitsiou, PhD Assistant Professor Department of Biomedical and Health Information Sciences College of Applied Health Sciences University of
More informationTo evaluate a single epidemiological article we need to know and discuss the methods used in the underlying study.
Critical reading 45 6 Critical reading As already mentioned in previous chapters, there are always effects that occur by chance, as well as systematic biases that can falsify the results in population
More informationIn this second module in the clinical trials series, we will focus on design considerations for Phase III clinical trials. Phase III clinical trials
In this second module in the clinical trials series, we will focus on design considerations for Phase III clinical trials. Phase III clinical trials are comparative, large scale studies that typically
More informationThis article is the second in a series in which I
COMMON STATISTICAL ERRORS EVEN YOU CAN FIND* PART 2: ERRORS IN MULTIVARIATE ANALYSES AND IN INTERPRETING DIFFERENCES BETWEEN GROUPS Tom Lang, MA Tom Lang Communications This article is the second in a
More informationUnderstandable Statistics
Understandable Statistics correlated to the Advanced Placement Program Course Description for Statistics Prepared for Alabama CC2 6/2003 2003 Understandable Statistics 2003 correlated to the Advanced Placement
More informationThe Logic of Data Analysis Using Statistical Techniques M. E. Swisher, 2016
The Logic of Data Analysis Using Statistical Techniques M. E. Swisher, 2016 This course does not cover how to perform statistical tests on SPSS or any other computer program. There are several courses
More informationGLOSSARY OF GENERAL TERMS
GLOSSARY OF GENERAL TERMS Absolute risk reduction Absolute risk reduction (ARR) is the difference between the event rate in the control group (CER) and the event rate in the treated group (EER). ARR =
More informationHow to craft the Approach section of an R grant application
How to craft the Approach section of an R grant application David Elashoff, PhD Professor of Medicine and Biostatistics Director, Department of Medicine Statistics Core Leader, CTSI Biostatistics Program
More informationProtocol Development: The Guiding Light of Any Clinical Study
Protocol Development: The Guiding Light of Any Clinical Study Susan G. Fisher, Ph.D. Chair, Department of Clinical Sciences 1 Introduction Importance/ relevance/ gaps in knowledge Specific purpose of the
More informationWhat you should know before you collect data. BAE 815 (Fall 2017) Dr. Zifei Liu
What you should know before you collect data BAE 815 (Fall 2017) Dr. Zifei Liu Zifeiliu@ksu.edu Types and levels of study Descriptive statistics Inferential statistics How to choose a statistical test
More informationCommon Statistical Issues in Biomedical Research
Common Statistical Issues in Biomedical Research Howard Cabral, Ph.D., M.P.H. Boston University CTSI Boston University School of Public Health Department of Biostatistics May 15, 2013 1 Overview of Basic
More informationLearning Objectives 9/9/2013. Hypothesis Testing. Conflicts of Interest. Descriptive statistics: Numerical methods Measures of Central Tendency
Conflicts of Interest I have no conflict of interest to disclose Biostatistics Kevin M. Sowinski, Pharm.D., FCCP Last-Chance Ambulatory Care Webinar Thursday, September 5, 2013 Learning Objectives For
More informationBiostatistics 3. Developed by Pfizer. March 2018
BROUGHT TO YOU BY Biostatistics 3 Developed by Pfizer March 2018 This learning module is intended for UK healthcare professionals only. Job bag: PP-GEP-GBR-0986 Date of preparation March 2018. Agenda I.
More informationModule 5. The Epidemiological Basis of Randomised Controlled Trials. Landon Myer School of Public Health & Family Medicine, University of Cape Town
Module 5 The Epidemiological Basis of Randomised Controlled Trials Landon Myer School of Public Health & Family Medicine, University of Cape Town Introduction The Randomised Controlled Trial (RCT) is the
More informationStatistics is the science of collecting, organizing, presenting, analyzing, and interpreting data to assist in making effective decisions
Readings: OpenStax Textbook - Chapters 1 5 (online) Appendix D & E (online) Plous - Chapters 1, 5, 6, 13 (online) Introductory comments Describe how familiarity with statistical methods can - be associated
More informationEvidence-Based Medicine Journal Club. A Primer in Statistics, Study Design, and Epidemiology. August, 2013
Evidence-Based Medicine Journal Club A Primer in Statistics, Study Design, and Epidemiology August, 2013 Rationale for EBM Conscientious, explicit, and judicious use Beyond clinical experience and physiologic
More informationGATE CAT Intervention RCT/Cohort Studies
GATE: a Graphic Approach To Evidence based practice updates from previous version in red Critically Appraised Topic (CAT): Applying the 5 steps of Evidence Based Practice Using evidence about interventions
More informationQuantitative Methods in Computing Education Research (A brief overview tips and techniques)
Quantitative Methods in Computing Education Research (A brief overview tips and techniques) Dr Judy Sheard Senior Lecturer Co-Director, Computing Education Research Group Monash University judy.sheard@monash.edu
More informationThe RoB 2.0 tool (individually randomized, cross-over trials)
The RoB 2.0 tool (individually randomized, cross-over trials) Study design Randomized parallel group trial Cluster-randomized trial Randomized cross-over or other matched design Specify which outcome is
More informationChapter 13 Summary Experiments and Observational Studies
Chapter 13 Summary Experiments and Observational Studies What have we learned? We can recognize sample surveys, observational studies, and randomized comparative experiments. o These methods collect data
More informationThe role of Randomized Controlled Trials
The role of Randomized Controlled Trials Dr. Georgia Salanti Lecturer in Epidemiology University of Ioannina School of Medicine Outline Understanding study designs and the role of confounding Observational
More informationChapter 5: Producing Data
Chapter 5: Producing Data Key Vocabulary: observational study vs. experiment confounded variables population vs. sample sampling vs. census sample design voluntary response sampling convenience sampling
More informationTable of Contents. Plots. Essential Statistics for Nursing Research 1/12/2017
Essential Statistics for Nursing Research Kristen Carlin, MPH Seattle Nursing Research Workshop January 30, 2017 Table of Contents Plots Descriptive statistics Sample size/power Correlations Hypothesis
More informationGambling attitudes and misconceptions
FINDINGS The results have been presented showing the effect sizes of interventions. When heterogeneity was absent the studies were pooled. However, the confidence intervals should be considered with caution.
More informationEvidence-based practice tutorial Critical Appraisal Skills
Evidence-based practice tutorial Critical Appraisal Skills Earlier evidence based practice tutorials have focussed on skills to search various useful sites on the internet for evidence. Anyone who has
More informationThings you need to know about the Normal Distribution. How to use your statistical calculator to calculate The mean The SD of a set of data points.
Things you need to know about the Normal Distribution How to use your statistical calculator to calculate The mean The SD of a set of data points. The formula for the Variance (SD 2 ) The formula for the
More informationChapter 13. Experiments and Observational Studies. Copyright 2012, 2008, 2005 Pearson Education, Inc.
Chapter 13 Experiments and Observational Studies Copyright 2012, 2008, 2005 Pearson Education, Inc. Observational Studies In an observational study, researchers don t assign choices; they simply observe
More information9/4/2013. Decision Errors. Hypothesis Testing. Conflicts of Interest. Descriptive statistics: Numerical methods Measures of Central Tendency
Conflicts of Interest I have no conflict of interest to disclose Biostatistics Kevin M. Sowinski, Pharm.D., FCCP Pharmacotherapy Webinar Review Course Tuesday, September 3, 2013 Descriptive statistics:
More informationExperimental Design. Terminology. Chusak Okascharoen, MD, PhD September 19 th, Experimental study Clinical trial Randomized controlled trial
Experimental Design Chusak Okascharoen, MD, PhD September 19 th, 2016 Terminology Experimental study Clinical trial Randomized controlled trial 1 PHASES OF CLINICAL TRIALS Phase I: First-time-in-man studies
More informationSafeguarding public health Subgroup Analyses: Important, Infuriating and Intractable
Safeguarding public health Subgroup Analyses: Important, Infuriating and Intractable The views expressed herein are not necessarily those of MHRA, EMA, EMA committees or their working parties. Rob Hemmings
More informationPhD Course in Biostatistics
PhD Course in Biostatistics Univ.-Prof. DI Dr. Andrea Berghold Institute for Medical Informatics, Statistics and Documentation Medical University of Graz andrea.berghold@medunigraz.at Content Introduction
More informationThe influence of CONSORT on the quality of reports of RCTs: An updated review. Thanks to MRC (UK), and CIHR (Canada) for funding support
The influence of CONSORT on the quality of reports of RCTs: An updated review Thanks to MRC (UK), and CIHR (Canada) for funding support Background In 1996 in response to concerns about the quality of reporting
More informationStrategies for data analysis: I. Observational studies
Strategies for data analysis: I. Observational studies Gilda Piaggio UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction World Health Organization
More informationGRADE. Grading of Recommendations Assessment, Development and Evaluation. British Association of Dermatologists April 2018
GRADE Grading of Recommendations Assessment, Development and Evaluation British Association of Dermatologists April 2018 Previous grading system Level of evidence Strength of recommendation Level of evidence
More informationOverview. Goals of Interpretation. Methodology. Reasons to Read and Evaluate
Overview Critical Literature Evaluation and Biostatistics Ahl Ashley N. Lewis, PharmD, BCPS Clinical Specialist, Drug Information UNC Hospitals Background Review of basic statistics Statistical tests Clinical
More informationSystematic Reviews. Simon Gates 8 March 2007
Systematic Reviews Simon Gates 8 March 2007 Contents Reviewing of research Why we need reviews Traditional narrative reviews Systematic reviews Components of systematic reviews Conclusions Key reference
More informationRecent developments for combining evidence within evidence streams: bias-adjusted meta-analysis
EFSA/EBTC Colloquium, 25 October 2017 Recent developments for combining evidence within evidence streams: bias-adjusted meta-analysis Julian Higgins University of Bristol 1 Introduction to concepts Standard
More informationIAPT: Regression. Regression analyses
Regression analyses IAPT: Regression Regression is the rather strange name given to a set of methods for predicting one variable from another. The data shown in Table 1 and come from a student project
More informationAssessing risk of bias
Assessing risk of bias Norwegian Research School for Global Health Atle Fretheim Research Director, Norwegian Institute of Public Health Professor II, Uiniversity of Oslo Goal for the day We all have an
More informationDepartment of OUTCOMES RESEARCH
Department of OUTCOMES RESEARCH Clinical Research Design Sources of Error Types of Clinical Research Randomized Trials! Daniel I. Sessler, M.D. Professor and Chair Department of OUTCOMES RESEARCH The Cleveland
More informationLive WebEx meeting agenda
10:00am 10:30am Using OpenMeta[Analyst] to extract quantitative data from published literature Live WebEx meeting agenda August 25, 10:00am-12:00pm ET 10:30am 11:20am Lecture (this will be recorded) 11:20am
More informationSystematic Reviews and Meta- Analysis in Kidney Transplantation
Systematic Reviews and Meta- Analysis in Kidney Transplantation Greg Knoll MD MSc Associate Professor of Medicine Medical Director, Kidney Transplantation University of Ottawa and The Ottawa Hospital KRESCENT
More informationHOW STATISTICS IMPACT PHARMACY PRACTICE?
HOW STATISTICS IMPACT PHARMACY PRACTICE? CPPD at NCCR 13 th June, 2013 Mohamed Izham M.I., PhD Professor in Social & Administrative Pharmacy Learning objective.. At the end of the presentation pharmacists
More informationBiostatistics for Med Students. Lecture 1
Biostatistics for Med Students Lecture 1 John J. Chen, Ph.D. Professor & Director of Biostatistics Core UH JABSOM JABSOM MD7 February 14, 2018 Lecture note: http://biostat.jabsom.hawaii.edu/education/training.html
More informationStudy design continued: intervention studies. Outline. Repetition principal approaches. Gustaf Edgren, PhD Karolinska Institutet.
Study design continued: intervention studies Gustaf Edgren, PhD Karolinska Institutet Background Outline Uncontrolled trials Non randomized, controlled trials Randomized controlled trials (with an overview
More informationCity, University of London Institutional Repository
City Research Online City, University of London Institutional Repository Citation: Burmeister, E. and Aitken, L. M. (2012). Sample size: How many is enough?. Australian Critical Care, 25(4), pp. 271-274.
More informationΚριτική αξιολόγηση τυχαιοποιημένης κλινικής δοκιμής Άρης Λιάκος, MD MSc Ειδικευόμενος Παθολογίας, Υποψήφιος Διδάκτωρ
Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης Σχολή Επιστημών Υγείας Τμήμα Ιατρικής Πρόγραμμα Μεταπτυχιακών Σπουδών «Ερευνητική Μεθοδολογία στην Ιατρική και τις Επιστήμες Υγείας» Μάθημα: Ιατρική Βασισμένη στην
More informationCHECK-LISTS AND Tools DR F. R E Z A E I DR E. G H A D E R I K U R D I S TA N U N I V E R S I T Y O F M E D I C A L S C I E N C E S
CHECK-LISTS AND Tools DR F. R E Z A E I DR E. G H A D E R I K U R D I S TA N U N I V E R S I T Y O F M E D I C A L S C I E N C E S What is critical appraisal? Critical appraisal is the assessment of evidence
More informationStrategies for handling missing data in randomised trials
Strategies for handling missing data in randomised trials NIHR statistical meeting London, 13th February 2012 Ian White MRC Biostatistics Unit, Cambridge, UK Plan 1. Why do missing data matter? 2. Popular
More informationConducting and managing randomised controlled trials (RCTs)
Conducting and managing randomised controlled trials (RCTs) Introduction Study Design We often wish to investigate the efficacy of new treatments and interventions on patient outcomes In this session,
More informationEvidence Based Medicine
Course Goals Goals 1. Understand basic concepts of evidence based medicine (EBM) and how EBM facilitates optimal patient care. 2. Develop a basic understanding of how clinical research studies are designed
More informationImproving reporting for observational studies: STROBE statement
Improving reporting for observational studies: STROBE statement Technical meeting on the reporting of human studies submitted for the scientific substantiation of health claims EFSA Parma 20 November 2013
More informationUnit 1 Exploring and Understanding Data
Unit 1 Exploring and Understanding Data Area Principle Bar Chart Boxplot Conditional Distribution Dotplot Empirical Rule Five Number Summary Frequency Distribution Frequency Polygon Histogram Interquartile
More informationThursday, April 25, 13. Intervention Studies
Intervention Studies Outline Introduction Advantages and disadvantages Avoidance of bias Parallel group studies Cross-over studies 2 Introduction Intervention study, or clinical trial, is an experiment
More informationProgramme Name: Climate Schools: Alcohol and drug education courses
STUDY REFERENCE: C/ADEPIS01 Programme Name: Climate Schools: Alcohol and drug education courses Contact Details: Nicola Newton, University of New South Wales, email: n.newton@unsw.edu.au Natasha Nair,
More informationFixed Effect Combining
Meta-Analysis Workshop (part 2) Michael LaValley December 12 th 2014 Villanova University Fixed Effect Combining Each study i provides an effect size estimate d i of the population value For the inverse
More informationGuidelines for Reporting Non-Randomised Studies
Revised and edited by Renatus Ziegler B.C. Reeves a W. Gaus b a Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, Great Britain b Biometrie und Medizinische Dokumentation,
More informationLecture 5 Conducting Interviews and Focus Groups
Lecture 5 Conducting Interviews and Focus Groups Talking to participants enables in-depth information about the experiences of health and illness; and of factors that influence health and illness behaviour
More informationbaseline comparisons in RCTs
Stefan L. K. Gruijters Maastricht University Introduction Checks on baseline differences in randomized controlled trials (RCTs) are often done using nullhypothesis significance tests (NHSTs). In a quick
More informationCRITICAL APPRAISAL AP DR JEMAIMA CHE HAMZAH MD (UKM) MS (OFTAL) UKM PHD (UK) DEPARTMENT OF OPHTHALMOLOGY UKM MEDICAL CENTRE
CRITICAL APPRAISAL AP DR JEMAIMA CHE HAMZAH MD (UKM) MS (OFTAL) UKM PHD (UK) DEPARTMENT OF OPHTHALMOLOGY UKM MEDICAL CENTRE MINGGU PENYELIDIKAN PERUBATAN & KESIHATAN PPUKM Lecture content Introduction
More informationChapter 5: Field experimental designs in agriculture
Chapter 5: Field experimental designs in agriculture Jose Crossa Biometrics and Statistics Unit Crop Research Informatics Lab (CRIL) CIMMYT. Int. Apdo. Postal 6-641, 06600 Mexico, DF, Mexico Introduction
More informationClinical Epidemiology for the uninitiated
Clinical epidemiologist have one foot in clinical care and the other in clinical practice research. As clinical epidemiologists we apply a wide array of scientific principles, strategies and tactics to
More informationAn introduction to power and sample size estimation
453 STATISTICS An introduction to power and sample size estimation S R Jones, S Carley, M Harrison... Emerg Med J 2003;20:453 458 The importance of power and sample size estimation for study design and
More informationChecklist for Randomized Controlled Trials. The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews
The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews Checklist for Randomized Controlled Trials http://joannabriggs.org/research/critical-appraisal-tools.html www.joannabriggs.org
More informationReadings: Textbook readings: OpenStax - Chapters 1 4 Online readings: Appendix D, E & F Online readings: Plous - Chapters 1, 5, 6, 13
Readings: Textbook readings: OpenStax - Chapters 1 4 Online readings: Appendix D, E & F Online readings: Plous - Chapters 1, 5, 6, 13 Introductory comments Describe how familiarity with statistical methods
More informationCONSORT 2010 checklist of information to include when reporting a randomised trial*
Supplemental Figures for: Ramosetron Versus Ondansetron in Combination with Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-induced Nausea and Vomiting: A Multicenter,
More informationBIOSTATISTICAL METHODS
BIOSTATISTICAL METHODS FOR TRANSLATIONAL & CLINICAL RESEARCH PROPENSITY SCORE Confounding Definition: A situation in which the effect or association between an exposure (a predictor or risk factor) and
More informationPropensity Score Methods for Estimating Causality in the Absence of Random Assignment: Applications for Child Care Policy Research
2012 CCPRC Meeting Methodology Presession Workshop October 23, 2012, 2:00-5:00 p.m. Propensity Score Methods for Estimating Causality in the Absence of Random Assignment: Applications for Child Care Policy
More informationCopyright GRADE ING THE QUALITY OF EVIDENCE AND STRENGTH OF RECOMMENDATIONS NANCY SANTESSO, RD, PHD
GRADE ING THE QUALITY OF EVIDENCE AND STRENGTH OF RECOMMENDATIONS NANCY SANTESSO, RD, PHD ASSISTANT PROFESSOR DEPARTMENT OF CLINICAL EPIDEMIOLOGY AND BIOSTATISTICS, MCMASTER UNIVERSITY Nancy Santesso,
More information11 questions to help you make sense of a case control study
Critical Appraisal Skills Programme (CASP) making sense of evidence 11 questions to help you make sense of a case control study How to use this appraisal tool Three broad issues need to be considered when
More informationBIOSTATISTICAL METHODS
BIOSTATISTICAL METHODS FOR TRANSLATIONAL & CLINICAL RESEARCH Designs on Micro Scale: DESIGNING CLINICAL RESEARCH THE ANATOMY & PHYSIOLOGY OF CLINICAL RESEARCH We form or evaluate a research or research
More informationHow to use this appraisal tool: Three broad issues need to be considered when appraising a case control study:
CASP Checklist: 11 questions to help you make sense of a Case Control Study How to use this appraisal tool: Three broad issues need to be considered when appraising a case control study: Are the results
More informationSchool of Dentistry. What is a systematic review?
School of Dentistry What is a systematic review? Screen Shot 2012-12-12 at 09.38.42 Where do I find the best evidence? The Literature Information overload 2 million articles published a year 20,000 biomedical
More information4/10/2018. Choosing a study design to answer a specific research question. Importance of study design. Types of study design. Types of study design
Choosing a study design to answer a specific research question Importance of study design Will determine how you collect, analyse and interpret your data Helps you decide what resources you need Impact
More informationGuidance Document for Claims Based on Non-Inferiority Trials
Guidance Document for Claims Based on Non-Inferiority Trials February 2013 1 Non-Inferiority Trials Checklist Item No Checklist Item (clients can use this tool to help make decisions regarding use of non-inferiority
More informationBiostatistics II
Biostatistics II 514-5509 Course Description: Modern multivariable statistical analysis based on the concept of generalized linear models. Includes linear, logistic, and Poisson regression, survival analysis,
More informationDesign and analysis of clinical trials
Design and analysis of clinical trials Lecture 3 1.Basic Design Considerations 2.Sample Size determinationa 3.Randomization 2018-01-31 Previous Lectures Definition of a clinical trial The drug development
More informationSPRING GROVE AREA SCHOOL DISTRICT. Course Description. Instructional Strategies, Learning Practices, Activities, and Experiences.
SPRING GROVE AREA SCHOOL DISTRICT PLANNED COURSE OVERVIEW Course Title: Basic Introductory Statistics Grade Level(s): 11-12 Units of Credit: 1 Classification: Elective Length of Course: 30 cycles Periods
More informationTeaching critical appraisal of randomised controlled trials
Teaching critical appraisal of randomised controlled trials Dr Kamal R. Mahtani BSc PhD MBBS PGDip MRCGP Deputy Director Centre for Evidence Based Medicine University of Oxford November 2014 1 objectives
More informationCochrane Pregnancy and Childbirth Group Methodological Guidelines
Cochrane Pregnancy and Childbirth Group Methodological Guidelines [Prepared by Simon Gates: July 2009, updated July 2012] These guidelines are intended to aid quality and consistency across the reviews
More informationSampling. (James Madison University) January 9, / 13
Sampling The population is the entire group of individuals about which we want information. A sample is a part of the population from which we actually collect information. A sampling design describes
More informationEvidence Informed Practice Online Learning Module Glossary
Term Abstract Associations Attrition Bias Background and Significance Baseline Basic Science Bias Blinding Definition An abstract is a summary of a research article. It usually includes the purpose, methods,
More informationLecture II: Difference in Difference. Causality is difficult to Show from cross
Review Lecture II: Regression Discontinuity and Difference in Difference From Lecture I Causality is difficult to Show from cross sectional observational studies What caused what? X caused Y, Y caused
More informationCRITICAL APPRAISAL SKILLS PROGRAMME Making sense of evidence about clinical effectiveness. 11 questions to help you make sense of case control study
CRITICAL APPRAISAL SKILLS PROGRAMME Making sense of evidence about clinical effectiveness 11 questions to help you make sense of case control study General comments Three broad issues need to be considered
More informationStatistics is the science of collecting, organizing, presenting, analyzing, and interpreting data to assist in making effective decisions
Readings: OpenStax Textbook - Chapters 1 5 (online) Appendix D & E (online) Plous - Chapters 1, 5, 6, 13 (online) Introductory comments Describe how familiarity with statistical methods can - be associated
More informationDescribe what is meant by a placebo Contrast the double-blind procedure with the single-blind procedure Review the structure for organizing a memo
Please note the page numbers listed for the Lind book may vary by a page or two depending on which version of the textbook you have. Readings: Lind 1 11 (with emphasis on chapters 10, 11) Please note chapter
More informationREVIEW FOR THE PREVIOUS LECTURE
Slide 2-1 Calculator: The same calculator policies as for the ACT hold for STT 315: http://www.actstudent.org/faq/answers/calculator.html. It is highly recommended that you have a TI-84, as this is the
More informationQuantitative Research Methods and Tools
Quantitative Research Methods and Tools Fraser Health Authority, 2011 The Fraser Health Authority ( FH ) authorizes the use, reproduction and/or modification of this publication for purposes other than
More informationPubH 7470: STATISTICS FOR TRANSLATIONAL & CLINICAL RESEARCH
PubH 7470: STATISTICS FOR TRANSLATIONAL & CLINICAL RESEARCH Instructor: Chap T. Le, Ph.D. Distinguished Professor of Biostatistics Basic Issues: COURSE INTRODUCTION BIOSTATISTICS BIOSTATISTICS is the Biomedical
More information